Takeda Pharmaceutical Co Ltd (TAK, TKPHF)

CIK 1395064 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Takeda Pharmaceutical Co Ltd.

Recent SEC filings

FiledFormAccession number
Sep 10, 20261440001493152-26-042079
Sep 3, 202640001395064-26-000335
Sep 2, 20261440001959173-26-006664
Aug 31, 20266-K0001395064-26-000331
Aug 21, 202640001493152-26-039693
Aug 19, 202640001493152-26-039214
Aug 19, 20261440001959173-26-006231
Aug 14, 20261440001493152-26-038353
Aug 12, 202640001493152-26-037515
Aug 12, 202640001493152-26-037509
Aug 12, 202640001493152-26-037514
Aug 12, 202640001493152-26-037352
Aug 12, 202640001493152-26-037494
Aug 12, 202640001493152-26-037502
Aug 12, 202640001493152-26-037507
Aug 12, 202640001493152-26-037351
Aug 12, 202640001493152-26-037484
Aug 12, 202640001493152-26-037513
Aug 12, 202640001493152-26-037480
Aug 12, 202640001493152-26-037505
Aug 12, 202640001493152-26-037482
Aug 12, 202640001493152-26-037486
Aug 12, 202640001493152-26-037499
Aug 10, 20261440001493152-26-036878
Aug 6, 20266-K0001395064-26-000329